Copyright
©The Author(s) 2015.
World J Diabetes. Jul 25, 2015; 6(8): 1045-1056
Published online Jul 25, 2015. doi: 10.4239/wjd.v6.i8.1045
Published online Jul 25, 2015. doi: 10.4239/wjd.v6.i8.1045
Figure 5 Comparison between glycated albumin and hemoglobin A1c during pregnancy and the incidence of neonatal complications.
For GA (A) and HbA1c (B) measured during the end stage of pregnancy, the incidence of neonatal complications was compared between the group of women whose GA or HbA1c was within the reference range (GA < 15.8%; HbA1c < 5.8%) and the group of women whose GA or HbA1c exceeded the reference range (GA ≥ 15.8%; HbA1c ≥ 5.8%) (modified from Shimizu et al[75]). HbA1c: Hemoglobin A1c; GA: Glycated albumin.
- Citation: Hashimoto K, Koga M. Indicators of glycemic control in patients with gestational diabetes mellitus and pregnant women with diabetes mellitus. World J Diabetes 2015; 6(8): 1045-1056
- URL: https://www.wjgnet.com/1948-9358/full/v6/i8/1045.htm
- DOI: https://dx.doi.org/10.4239/wjd.v6.i8.1045